April 17, 2014 9:45 PM ET

Biotechnology

Company Overview of Inimex Pharmaceuticals Inc.

Executive Profile

H. Grant Stiver M.D.

Member of Clinical Advisory Board, Inimex Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. H. Grant Stiver, M.D., serves as Assistant Head of the Division of Infectious Disease at the University of British Columbia and also serves as its Professor. Prior to Dr. Stiver's time at UBC, he served as Acting Head of the Section of Infectious Diseases and a Professor of Medicine and Medical Microbiology at the University of Manitoba. He has been a pioneer of innovative management of infectious disease, including the practice of home self-administration of intravenous ...

Corporate Headquarters

3650 Wesbrook Mall
Coquitlam, British Columbia V3J 7V6

Canada

Phone: 604-225-2251
Fax: 604-225-2257

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
University of Manitoba

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inimex Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.